Status In progress
Technology type Device
Decision Selected
Reason for decision Anticipate the topic will be of importance to patients, carers, professionals, commissioners and the health of the public to ensure clinical benefit is realised, inequalities in use addressed, and help them make the best use of NHS resources
Further information In appraisal
Process Cost Comparison Standard
ID number 6376

Provisional Schedule

Expected publication 03 July 2024

Project Team

Project lead Louise Jafferally

Email enquiries

External Assessment Group Centre for Reviews and Dissemination and Centre for Health Economics, University of York

Stakeholders

Companies sponsors Terumo Europe (QuiremSpheres)
Others Department of Health & Social Care
  NHS England
Patient carer groups None
Professional groups Association of Cancer Physicians
  British Association for the Study of the Liver
  Cancer Research UK
  Royal College of Physicians
  Royal College of Radiologists
Associated public health groups None
Comparator companies Boston Scientific (TheraSphere)
  Sirtex Medical (SIR-Spheres)
General commentators All Wales Therapeutics and Toxicology Centre
  British National Formulary
  Department of Health, Social Services and Public Safety for Northern Ireland
  Healthcare Improvement Scotland
  Medicines and Healthcare products Regulatory Agency
  Scottish Medicines Consortium
  Welsh Government
  Welsh Health Specialised Services Committee
Relevant research groups Institute of Cancer Research

Timeline

Key events during the development of the guidance:

Date Update
12 December 2023 Invitation to participate
28 November 2023 - 04 December 2023 Consultation on suggested remit, draft scope and provisional stakeholder list of consultees and commentators
27 November 2023 The appraisal is expected to start during late November 2023 with a consultation on the draft scope. It is then anticipated that the final scope will be released along with an invitation to participate in the appraisal during mid-December 2023.
24 November 2023 In progress

For further information on our processes and methods, please see our CHTE processes and methods manual